Buffett just messed things up for Teva short-sellers
Add BT as a preferred sourceIT'S not like there was any real risk in shorting an easy target like Teva Pharmaceutical Industries. Warren Buffett could come along to destroy your bet, but what were the odds of that happening?
Oops.
It's not a happy Valentine's Day for Teva short-sellers. After the market closed Wednesday, a filing from Buffett's Berkshire Hathaway disclosed that it made only one new investment during the latest quarter. Unluckily for Teva bears, it was the Israeli generic-drug maker they've been betting against to the tune of US$1.2 billion.
TRENDING NOW
When every phone becomes a satellite phone, what happens to Asia’s telcos?
Lily Ler to step down as CEO of Mapletree Industrial Trust manager
Jardine C&C selling Singapore, Malaysia dealerships to Indonesia’s Chandra Asri for US$221 million gain
Digital Realty, STT GDC among data centre operators awarded 50 MW of new capacity in Singapore
